Decoy Therapeutics (DCOY) Assets (2014 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Assets of $8.4 million for Q1 2026, up 260.06% year-over-year from $2.3 million in Q1 2025, and down 23.82% quarter-over-quarter from $11.1 million in Q4 2025.
Decoy Therapeutics (DCOY) Assets (2014 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Assets for 13 consecutive years, with $8.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 260.06% year-over-year to $8.4 million; the TTM figure through Mar 2026 stood at $8.4 million (up 260.06% YoY), while the FY2025 annual figure was $11.1 million, up 265.76% from the prior year.
- Assets declined to $8.4 million in Q1 2026 per DCOY's latest filing, from $11.1 million in the prior quarter.
- Across five years, Assets topped out at $35.5 million in Q1 2022 and bottomed at $1.4 million in Q2 2025.
- Historically, Assets has averaged $10.9 million across 5 years, with a median of $8.4 million in 2023.
- Annual changes were most pronounced in 2023 — Assets sank 71.68% — and 2025, when it jumped 265.76%.
- Decoy Therapeutics' Assets stood at $14.7 million in 2022, then sank by 55.04% to $6.6 million in 2023, then tumbled by 54.1% to $3.0 million in 2024, then surged by 265.76% to $11.1 million in 2025, then declined by 23.82% to $8.4 million in 2026.
- Business Quant data shows DCOY's Assets at $8.4 million in Q1 2026, $11.1 million in Q4 2025, and $6.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | 9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.00 Mn |
| Mar 31, 2026 | 8.42 Mn |
| Dec 31, 2025 | 11.06 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Dec 31, 2024 | 3.02 Mn |
| Sep 30, 2024 | 3.86 Mn |
| Jun 30, 2024 | 3.55 Mn |
| Mar 31, 2024 | 4.88 Mn |
| Dec 31, 2023 | 6.59 Mn |
| Sep 30, 2023 | 8.40 Mn |
| Jun 30, 2023 | 12.06 Mn |
| Mar 31, 2023 | 10.06 Mn |
| Dec 31, 2022 | 14.65 Mn |
| Sep 30, 2022 | 19.72 Mn |
| Jun 30, 2022 | 33.65 Mn |
| Mar 31, 2022 | 35.51 Mn |
| Dec 31, 2021 | 40.83 Mn |
| Sep 30, 2021 | 44.26 Mn |